Alternatives to Haplotype Labs

AI foundation models predicting patient drug response to de-risk clinical trials.

Enterprise AI platform for finance, automating data synthesis, analysis, and presentation with traceable citations.

Alphabet X's per-plant AI crop intelligence, now embedded in Driscoll's and John Deere after 2024 acquisition

Autonomous AI scientist for biopharma R&D, powered by multimodal patient data

AI-driven drug discovery platform using phenomics, massive datasets, and wet-lab automation

AI-driven end-to-end drug discovery and biologics manufacturing platform

Mechanistic interpretability platform to understand, debug, and design AI models

Highly selective small-molecule drug discovery for oncology, immunology, and metabolic diseases.

End-to-end generative AI drug discovery platform from target ID to clinical trials

Automate enterprise-scale research, analysis, and report generation with agentic AI.

Flatiron Health: Oncology real-world evidence platform with AI-powered insights for cancer research and point-of-care decisions.

AI foundation models for precision neurology, cutting CNS trial sizes.

Generative AI and robotics for autonomous drug discovery, compressing the DMTA cycle to under two years.

Enterprise AI VoC platform turning 100% of customer feedback into measurable business outcomes

AI-powered clinical trial patient matching and recruitment from EMR data.

Physics-based molecular discovery platform for drug and materials design, now with agentic AI.

Independent carbon credit ratings, pricing intelligence, and market data for professional carbon market participants.

Cloud ELN, LIMS, and AI platform that unifies biotech R&D data.

FDA-cleared AI platform for cancer pathology detection and biomarker discovery

Regulatory-cleared quantitative imaging biomarkers from MRI for radiology and biopharma

AI-powered precision oncology platform analyzing clinical and molecular data for personalized cancer care.

AI-native biotech using causal AI to decode human disease and accelerate drug discovery.

ML-guided protein engineering for multi-property co-optimization with private, compounding models.

AI-driven biomanufacturing for personalized stem cell therapies

AI drug discovery platform delivering life science intelligence for R&D decisions.

Enterprise AI pathology platform for diagnostics and drug development.

AI drug discovery platform turning >50PB cellular imaging and multi-omics data into clinical-stage therapies

AI agentic platform for multimodal R&D data analysis and workflow automation

AI drug discovery platform combining >50PB proprietary data with automated wet labs to design and validate optimized molecules.

Agentic AI platform for food & beverage trend intelligence, built on the deepest food data layer.